AAP FACTCHECK - Tobacco is a leading cause of cancer and is not a proven cure for the disease, despite claims online. False ...

Please provide your email address to receive an email when new articles are posted on . A universal screening and opt-out referral strategy may reduce disparities in tobacco treatment access and ...

Smoking cessation in advanced-stage cancer patients can extend life by about one year, highlighting its importance in cancer care. Innovative models like point-of-care tobacco treatment are ...

Clinical Management of Ovarian Function Suppression in Premenopausal Women With Breast Cancer: A Survey of Members of ASCO In 2017, the National Cancer Institute (NCI) funded the Cancer Center ...

Illustration courtesy of Vivian Chang This 3-part series looks at the current evidence for the treatment of SUDs. Part 3 reviews the use of GLP-1 receptor agonists and tobacco use. A variety of ...

Please provide your email address to receive an email when new articles are posted on . Tobacco treatment reach and smoking cessation rates were collected before and after implementation of a point-of ...

IQWiG has now published its final benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation, also in combination with each other, compared with no drug therapy.

Patients with chronic obstructive pulmonary disease (COPD) who smoke were less likely to receive tobacco dependence treatment (TDT) if they lived in rural areas or had longer travel times to care, ...